# HNSC data sets

## Bulk RNA-seq

### TCGA-HNSC

- Available on different data sources
- n = 528 (including non-primary tumors, normal cases), re-analyzed cohort n = 277 (primary tumors), adjuvantly treated cases n = 98 tumors
- Legacy or harmonized re-analyzed data versions are available

### LMU-KKG 08-13 and 13-16

- [GSE205308](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE205308) (08-13) and [GSE235223](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235223) (13-16)
- n = 72 + 134
- Adjuvantly treated tumors
- 3' Quantseq expression data, full-length RNAseq data for some cases

### CPTAC-HNSCC

- Available on [LinkedOmics](https://www.linkedomics.org/data_download/CPTAC-HNSCC/)
- n = 108
- log2 RSEM, upper-quartile normalized expression data
- Available clinical, protein expression, methylation, microRNA expression, etc. data levels

### Wichmann et al. cohort

- [GSE65858](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65858)
- n = 270 (including everything), n = 211 primary tumors
- log2-transformed and RSN normalized microarray expression data 

### Lohavanichbutr et al. cohort

- [GSE41613](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41613)
- n = 96 primary tumors
- Microarray expression data

### Foy et al. cohorts

- [Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors](https://doi.org/10.1016/j.dib.2022.108556)
- Targeted sequencing
- 2 HNSC data sets, details in the publication

### Waas et al. cohort

- [EGAS50000000714](https://ega-archive.org/datasets/EGAD50000000995)
- Bulk RNAseq of 88 HPV-neg. HNSCC patients and 45 paired patient-derived xenograft samples that successfully engrafted in mice

### Lin et al. cohort

- [GSE274788](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274788)
- Bulk RNAseq of isolated CD8+ T lymphocytes
- Cells from healthy individuals or from hypopharyngeal squamous cell carcinoma patients (irradiated or untreated)

### Obradovic et al. cohort

- All the files are [here](10.17632/yk8wj7xgdg.1) or on [GEO](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195832)
- Bulk RNAseq of locally advanced HNSCCs with nivolumab (anti-PD1) treatment: 28 patients with pre- and post-treatment data
- Treatment response data available

### Gao et al. cohort

- [GSE142083](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142083)
- Bulk RNAseq of 52 laryngeal squamous cell carcinoma (LSCC) and 53 paired adjacent normal mucosa tissues

### Cheng et al. cohort

- [GSE178537](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178537)
- 21 normal oral epithelia, 35 primary tumors, and 9 metastatic tumors from 21 patients (HNSCC)
- Sequenced tissues: normal part, intra-tumor part, invasive-front tumor part, lymph node metastasis tumor part
- Patient-level information [here](https://jitc.bmj.com/content/jitc/10/8/e004832/DC3/embed/inline-supplementary-material-3.xlsx)

## scRNA-seq

### Curated Cancer Cell Atlas (Weizmann Institute of Science)

- [Website](https://www.weizmann.ac.il/sites/3CA/head-and-neck)
- 4 scRNAseq HNSC cohorts are included

### Puram et al. cohort

- [GSE103322](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103322)
- 5901 annotated cells from 18 patients (10 with a higher number of epithelial cells)
- log2(TPM/10+1) normalized expression data

### Kürten et al. cohort

- [GSE164690](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164690)
- 134606 cells from 18 patients (12 HPV- and 6 HPV+)
- Cells are pre-sorted (CD45-, CD45+, PBL)

### Bill et al. cohort

- [GSE234933](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234933)
- 52 samples: 24 primary tumors, 16 local recurrences, 12 distant metastasis
- 37 HPV- and 15 HPV+ tumors

### Choi et al. cohort 

- [GSE181919](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE181919)
- 37 samples: 9 normal tissue, 4 leukoplakia, 20 primary cancers, 4 metastatic lymph node cancers
- HPV- and HPV+ tumors

### Luoma et al. cohort

- [GSE200996](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200996)
- Locally advanced OSCC
- Samples from 30 patients from 2 different cohorts (anti-PD-1 monotherapy, anti-PD-1+anti-CTLA-4 combination therapy)
- PBMC, tumor 

### Jenkins et al. cohort

- [Data location](https://cellxgene.cziscience.com/collections/3c34e6f1-6827-47dd-8e19-9edcd461893f), [processed data](https://zenodo.org/records/14284357)
- Normal and oropharynx squamous cell carcinoma
- 7 HPV+ tumors (31,386 cells), 3 HPV- tumors (19,814 cells) and 7 matched-normal mucosa (31,644 cells)
- [Publication](https://doi.org/10.1186/s12943-024-02191-9)

### Wickström et al. cohort

- [GSE252265](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi)
- 8 tongue carcinoma patients

### Greenwald et al. dataset

- [GSE157220](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157220)
- 198 cancer cell lines by single-cell RNA-seq with 10X chromium (19 HNSC cell lines)
  
### Obradovic et al. cohort

- All the files are [here](10.17632/yk8wj7xgdg.1) or on [GEO](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195832)
- Locally advanced HNSCCs with nivolumab (anti-PD1) treatment: 4 patients with pre- and post-treatment data
- Treatment response data available

## Spatial RNA-seq data

### Jenkins et al. cohort

- [Data location](https://zenodo.org/records/14284038))
- 13 samples (HPV- and HPV+ tumors)
- scRNAseq available (see above)

### Arora et al. cohort

- [GSE208253](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208253)
- [Processed data](https://figshare.com/articles/dataset/Spatial_transcriptomics_reveals_distinct_and_conserved_tumor_core_and_edge_architectures_that_predict_survival_and_targeted_therapy_response_/20304456/1)
- 12 samples from 10 HPV- OSCC patients

## Cell line data

#### 	Wiechec et. al data set

- [GSE178153](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178153)    
- Expression data of HNSCC cell lines grown without and with patient-matched CAFs in 2D    
- 5 cell lines grown with CAFs, and 5 cell lines grown without CAFs    
